June notebook: Major disruptions + panel reductions
Two big disruptions have impacted many data buyers this past month.
-
-
%20(1)%20(1).png)
How are data providers adapting to today’s regulatory environment?
Our Ask Brittany column will answer a commonly asked question from real data buyers and sellers. Email your submission, and we might answer it in next month's newsletter. Q: How are data providers adapting to today’s regulatory and compliance env... -
.jpg)
Vessels to ports: An alternative data perspective
Tariffs have driven demand for trade data. This report reviews key vendors in trade statistics, bills of lading, and vessel data for real-time tariff insights. -
Mapping Chinese manufacturing migration after the tariff shock
The 2018 Trump tariffs triggered a significant reorganisation of manufacturing activities in China and the rest of Asia. With the 2025 Trump administration implementing even higher tariffs, some Chinese corporations appear less surprised and better prepared, having initiated relocation strategies. In this review, we explore how trade flow and corporate data can reveal the reshaping of the global supply... -
People Moves, May 2025: Capula, Sensor Tower and Silver Point
In this month’s roundup, Capula hires a new market data manager, Sensor Tower promotes a new VP of Sales and Jump hires a new alternative data sourcing manager. -
.png)
Evolving investment trends: Alternative sources of labour market data
How has investor adoption evolved across the alternative labour market space? We cover the key datasets and highlight new entrants to watch. -
Most in-demand vendors from Neudata’s New York Summit
The AltDating round at May 2025’s New York Summit had nearly 200 data buyers and 250 vendor participants. From all of these choices and meetings, buyers showed the most interest in topics such as TikTok sentiment, clickstream and CPI signals. -
A primer on corporate actions
This report provides an overview of the corporate actions space, from sourcing practices to key provider comparisons. -
Must-know moves in data regulation: May
Welcome to the first edition of Must-know moves in data regulation. Each month, we break down the regulatory and legal developments shaping the data landscape and offer practical takeaways to help you stay ahead in a fast-moving environment. KEY ... -
Cures or crashes: Do clinical trial outcomes influence stock prices?
We explore a paper that analyses how clinical trial result announcements affect the stock prices of sponsoring companies.